We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

Monogram Orthopaedics Inc. Common Stock

Company price
None USD 0.00(0%)
Last update at 2025-11-06T20:10:50.355211Z
Market Cap
64.54M

Momentum Score

…

Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was founded in 2015 and is headquartered in Austin, Texas.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
1.53
Low
6.55
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
0.36M
Revenue Per Share
0.02
Gross Profit TTM
0.00M
Debt / Equity
0.04
ROE
-156.67%
Net Debt
-13.10M
ROCE
-50.33%
Diluted EPS TTM
-0.42

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -13.69M -11.81M -9.07M -1.80M -0.71M
Net income -13.69M -11.81M -9.07M -1.80M -0.71M
Selling general administrative 2.93M 1.90M 0.96M 1.25M 0.58M
Selling and marketing expenses 2.71M 3.27M 1.22M 0.21M 0.00M
Gross profit 0.00M 0.17M 0.00M - -
Reconciled depreciation 0.39M 0.32M 0.10M 0.03M -
Ebit -6.93M -10.23M -6.72M -1.67M -0.65M
Ebitda -6.54M -9.91M -6.62M -1.64M -0.62M
Depreciation and amortization 0.39M 0.32M 0.10M 0.03M 0.03M
Operating income -10.61M -10.28M -6.85M -1.68M -0.62M
Other operating expenses 10.36M 10.91M 6.85M 1.68M 0.65M
Interest expense - 0.02M 0.05M 0.12M 0.06M
Tax provision 0.00M 0.00M 0.00M 0.00M -
Interest income 0.10M 0.05M 0.13M 0.00M -
Net interest income 0.10M 0.03M 0.08M -0.12M -
Income tax expense 3.33M 0.02M 0.05M 0.00M -0.03M
Total revenue 0.00M 0.63M 0.00M 0.00M -
Total operating expenses 10.36M 10.45M 6.85M 1.68M 0.65M
Cost of revenue 0.00M 0.46M 0.00M - -
Total other income expense net -3.43M -1.56M -2.29M -0.12M -0.09M
Net income from continuing ops -13.69M -11.81M -9.07M -1.80M -
Net income applicable to common shares -13.69M -11.81M -9.07M -1.80M -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 16.58M 13.69M 8.72M 8.12M 2.62M
Intangible assets 0.55M 1.30M 1.51M 0.69M -
Other current assets 0.52M 0.00M -0.01M 0.75M 0.07M
Total liab 3.18M 9.54M 5.21M 3.13M 2.89M
Total stockholder equity 13.40M 4.15M 3.50M 4.99M -0.27M
Other current liab 0.23M 8.27M 4.55M 2.74M 0.52M
Common stock 0.03M 0.01M 0.01M 0.01M 0.00M
Capital stock 0.03M 0.02M 0.02M 0.01M 0.01M
Retained earnings -51.51M -37.76M -24.07M -12.26M -3.19M
Other liab - 0.00M - - -
Other assets 0.00M - - -0.00M -
Cash 13.59M 10.47M 5.54M 5.59M 2.32M
Total current liabilities 2.82M 9.05M 5.09M 2.98M 2.85M
Current deferred revenue 0.00M 0.75M 0.46M 0.21M 0.29M
Net debt -13.10M -9.86M -5.32M -5.38M -0.20M
Short term debt 0.13M 0.12M 0.09M 0.06M 2.08M
Short long term debt - - - - 2.08M
Short long term debt total 0.49M 0.61M 0.21M 0.21M 2.12M
Other stockholder equity 64.87M 41.89M 27.56M 17.23M 2.91M
Property plant equipment - 1.67M 1.23M 1.53M 0.24M
Total current assets 14.47M 11.26M 6.50M 6.43M 2.38M
Net tangible assets - 3.38M 2.53M 4.83M -0.28M
Net receivables 0.36M 0.16M 0.42M - -
Long term debt - - - - 0.05M
Inventory 0.00M 0.00M 0.56M - -
Accounts payable 2.46M 0.66M 0.45M 0.18M 0.25M
Accumulated other comprehensive income 0.00M - - - -
Non currrent assets other 0.15M - 0.01M 0.01M -
Non current assets total 2.11M 2.43M 2.21M 1.69M 0.24M
Capital lease obligations 0.49M 0.61M 0.21M 0.21M -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -0.24M -1.01M -1.33M -0.01M -
Change to liabilities 0.21M 0.27M -0.06M -0.02M -
Total cashflows from investing activities -0.24M -1.01M -1.33M -0.01M -
Net borrowings - - -0.76M -0.08M -
Total cash from financing activities 13.59M 10.12M 10.01M 2.45M 1.15M
Change to operating activities 0.50M 0.29M -0.75M 0.12M -
Net income -13.69M -11.81M -9.07M -1.80M -0.71M
Change in cash 4.93M -0.05M 3.27M 1.40M 0.69M
Begin period cash flow 5.54M 5.59M 2.32M 0.92M 0.24M
End period cash flow 10.47M 5.54M 5.59M 2.32M 0.92M
Total cash from operating activities -8.42M -9.17M -5.40M -1.05M -0.31M
Issuance of capital stock 13.59M 10.12M 10.77M 2.53M -
Depreciation 0.39M 0.32M 0.10M 0.03M 0.03M
Other cashflows from financing activities -0.24M -1.01M 10.85M 2.53M -0.15M
Change to netincome 4.18M 1.77M 4.38M 0.61M -
Capital expenditures 0.24M 1.01M 1.33M 0.01M 0.15M
Change in working capital 0.71M 0.56M -0.81M 0.10M 0.37M
Stock based compensation 0.74M 0.21M 2.16M 0.61M -
Other non cash items 3.43M 1.56M 2.22M - -
Free cash flow -8.66M -10.17M -6.74M -1.05M -0.46M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
ABT
Abbott Laboratories
-0.71
0.65%
108.58 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC
0.28
0.28%
101.89 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation
-2.16
0.68%
316.63 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG
-
-%
47.31 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

Monogram Orthopaedics Inc. Common Stock

Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was founded in 2015 and is headquartered in Austin, Texas.

3913 Todd Lane, Austin, TX, United States, 78744

512 399 2656

28

Name Title Year Born
Mr. Benjamin Sexson C.F.A. Chairman of the Board, President & CEO 1984
Dr. Douglas Unis Founder, Chief Medical Officer & Director 1969
Mr. Noel Knape CPA, M.B.A. Chief Financial Officer 1969
Dr. Kamran Shamaei Ph.D. Chief Technology Officer 1983
Chris Tyson Executive Vice President - MZ North America NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…